Advanced Cell Technology
Stem cell technology firm raises $17.75M in private placements
Published in Healthcare Mergers, Acquisitions and Ventures Week, October 15th, 2005
The convertible notes are convertible into 9,672,925 million shares of common stock at a price of $2.30 per share.
The investors also received warrants to purchase 4,836,462 million additional shares of common stock at a price of $2.53 per share exercisable for 5 years. T.R. Winston & Company acted as placement agent for the securities sold in this transaction.
The proceeds of the financing are expected to be used by the company for general corporate purposes and to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Aastrom Biosciences, Inc.
Stem cell technology company reports loss of $0.03 per share - Abaris, Inc.
IT company establishes life science division for pharma firms - Access Pharmaceuticals, Inc.
Polymer therapeutics developer reports status of cash position - Aceto Corp.
Pharmaceutical distributor reports income of $0.11 per share - AmerisourceBergen Corp.
Drug distribution firm completes sale of $900M in senior notes - AtriCure, Inc.
Surgical device maker reports 50.9% increase in revenue - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
